Necessity of concurrent chemotherapy in N2‐3 nasopharyngeal carcinoma treated with neoadjuvant chemotherapy of ≥3 cycles followed by intensity‐modulated radiotherapy

Necessity of concurrent chemotherapy in N2‐3 nasopharyngeal carcinoma treated with neoadjuvant chemotherapy of ≥3 cycles followed by intensity‐modulated radiotherapy

Abstract Concurrent chemotherapy (CCT) is used in locally advanced nasopharyngeal carcinoma (NPC) for improved local control, which could also be achieved by intensity‐modulated radiotherapy (IMRT). And for N2‐3 NPC, distant metastasis is the more important cause of death. This study aims to evaluat...

Full description

Bibliographic Details
Main Authors: Hui Chang, Liang Peng, Ya‐Lan Tao, Chen Chen, Wei‐Wei Xiao, Yong‐Hong Hu, Yuan‐Hong Gao
Format: Article
Language:English
Published: Wiley 2019-06-01
Series:Cancer Medicine
Subjects:
concurrent chemotherapy
N2‐3 disease
nasopharyngeal carcinoma
survival
toxicities
Online Access:https://doi.org/10.1002/cam4.2179

Similar Items

Similar Items